AI-Powered Product Quality & Risk Assessment
Use Cases / Quality

AI-Powered Product Quality & Risk Assessment

Present this use case
  • 01 Consolidated quality assessment across all data sources
  • 02 Continuous product robustness scoring for every product
  • 03 Predictive risk identification before failures occur
  • 04 Cross-product and cross-site risk intelligence
Scroll

What FDA Inspectors Cite

Product quality failures trace back to fragmented data, missing statistical rigour, and reactive risk management. These real 483 observations show what happens when quality assessment lacks consolidation and predictive capability.

§211.100

Process validation studies approved without evaluating intra-batch or inter-batch variability in critical quality attributes

Zydus Lifesciences Limited

August 29, 2024

Process Capability

Process performance qualification studies for US-market products did not include acceptance criteria for intra-batch or inter-batch variability. PPQ batches were approved without evaluating sources of potential variation in CQAs including assay, impurities, and pH. Sampling consisted of composite results rather than enhanced sampling designed to detect variability — the firm could not demonstrate its processes were capable of consistently meeting quality standards.

Insights generated using Leucine FDA TrackerExplore FDA Tracker

Why Product Quality Risks Go Undetected

Most pharmaceutical manufacturers can tell you whether a batch passed or failed. Few can tell you how robust a product is, which products are approaching quality boundaries, or where the next quality failure will come from. These operational barriers explain why.

Challenge 1/7

Quality Data Fragmented Across 8+ Enterprise Systems

  1. 01Batch yields in MES, analytical results in LIMS, material attributes in ERP, stability in a separate database — each system holds a piece of the quality picture
  2. 02QA teams manually export and reconcile data from 8+ systems to assess a single product’s quality posture
  3. 03No single platform correlates a yield drift with the raw material lot, equipment change, or environmental condition that caused it

Agentic Architecture

Five specialized AI agents orchestrated by Celestara, each equipped with domain-aware tools and pharma-specific skills, operating on a unified quality ontology that connects products, processes, materials, and quality events across your manufacturing network.

Data Layer

MES / eBMR
LIMS
ERP
Stability System
Supplier Quality
Environmental Monitoring
Deviation & CAPA History

Celestara

Orchestration Layer

Manages the quality ontology, orchestrates agent workflows with domain-specific tools, and enforces 21 CFR Part 11 compliance across the integration pipeline and all analytical operations

Data Integration
Cross-System IngestionSchema HarmonizationOntology Population
Ontology Reasoning
Product-Process-Material MappingCQA-CPP CorrelationImpact Tracing
Statistical Analysis
Cpk/Ppk TrendingMultivariate AnalysisControl Chart Generation
Risk Scoring
Robustness QuantificationPredictive ModelingRisk Signal Aggregation
Pattern Intelligence
Cross-Product CorrelationSupply Chain Risk MappingMulti-Site Trending

Quality Outputs

Product Risk Dashboard
Robustness Scores
Predictive Risk Alerts
Cross-Product Intelligence
Audit-Ready Reports

Product Quality & Risk Assessment in Celestara

1.Enterprise Data Integration and Harmonization

Celestara connects to every operational system through a purpose-built integration pipeline that normalizes heterogeneous data — structured database records, time-series sensor data, unstructured batch narratives, and supplier quality documents — into a unified data foundation. Data flows continuously, not in annual retrospective batches.

2.Quality Ontology Maps Product-Process-Material Relationships

Celestara maintains a quality ontology — a connected knowledge model that maps every product to its critical quality attributes, process parameters, raw materials, equipment, and historical quality events. When a material lot changes, the ontology traces which products, processes, and CQAs could be affected. This contextual reasoning is what makes predictive quality assessment possible.

3.Continuous Statistical Analysis and Capability Monitoring

AI agents perform continuous statistical analysis across every product — Cpk/Ppk trending, multivariate analysis, control charts — using the ontology to contextualize results. A capability drift in dissolution is automatically correlated with changes in raw material lots, equipment parameters, or environmental conditions. Analysis happens continuously, not annually.

4.Predictive Risk Scoring and Product Robustness Assessment

Each product receives a continuously updated robustness score derived from process capability indices, material quality signals, deviation trends, stability data, and manufacturing variability. Celestara aggregates signals across the quality ontology to identify products approaching quality boundaries before they cross them — turning reactive quality events into preventable ones.

5.Cross-Product and Cross-Site Risk Intelligence

Celestara correlates risk signals across products, sites, and supply chains. When a raw material supplier’s quality drifts, every product using that material is flagged. When a process parameter shift at one site affects quality, the system checks whether the same risk exists at other sites. Quality leaders see a single dashboard that ranks products by risk and recommends specific mitigation actions.

How Leucine Solves This

Purpose-built tools that address both the FDA compliance gaps and the operational barriers to effective product quality assessment and proactive risk management.

Celestara Quality Intelligence

Unified Quality Ontology Across All Data Sources

Celestara connects every quality-relevant system through an enterprise integration pipeline and builds a continuously updated quality ontology — a connected knowledge model that maps relationships between products, processes, materials, equipment, and quality events. AI agents equipped with domain-specific tools query this ontology to answer questions that no single system can answer alone: which material lots correlate with yield dips, which process parameters predict stability risk, and which products share equipment-related failure modes.

211.100211.110Quality Data Fragmented Across 8+ Enterprise SystemsProduct Robustness Is Not Systematically Measured

Capabilities

  • Enterprise integration pipeline connecting MES, LIMS, ERP, stability, supplier quality, and environmental monitoring into a unified data foundation
  • Quality ontology mapping product-process-material relationships with automatic impact tracing across the portfolio
  • AI agents with domain-aware tools that query cross-system data through the ontology in real time
  • 21 CFR Part 11 compliant audit trail on all data integration, ontology updates, and analytical operations

Measurable Impact

Real results from organisations using Celestara for continuous product quality assessment and predictive risk management

Risk Detection Speed

0x

Faster identification of emerging quality risks through continuous monitoring versus annual retrospective CPV reviews

Data Consolidation

0%

Quality-relevant data sources unified into a single ontology-backed model, up from typically 30–40% coverage in manual processes

Right First Time

0%

Absolute improvement in right-first-time rates through predictive risk mitigation and proactive process adjustments

Write-Off Reduction

0%

Decrease in batch write-offs and reject events through early risk signal detection and material-quality correlation

Powered by

Celestara

The AI-native data intelligence platform — orchestrating specialized agents to transform raw enterprise data into structured ontologies, automated pipelines, and actionable analytics.

Explore Celestara

Stop discovering quality risks after the write-off. Celestara AI agents continuously assess product robustness across your entire portfolio — correlating process data, material attributes, and quality events through a unified quality ontology to predict risks before they materialise. Shift from reactive compliance to predictive quality intelligence.